Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC25A6P2 is a processed human pseudogene corresponding to the solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 locus[7][9][1]. Unlike its parent gene SLC25A6, which encodes a mitochondrial ADP/ATP translocase involved in cellular energy metabolism, SLC25A6P2 does not produce a functional protein. Pseudogenes like SLC25A6P2 were once thought to be “junk DNA,” but there is growing evidence that some pseudogenes can exert regulatory effects at the RNA level, for example by acting as microRNA decoys or producing small interfering RNAs. However, no specific regulatory function or disease association is documented for SLC25A6P2 itself[8]. Its status as a pseudogene means it is not an established molecular target in drug discovery or clinical diagnostics.\n\nIf a canonical, protein-coding molecular target within the SLC25A6 family is required (sometimes called "ADP/ATP translocase 3"), that would refer to SLC25A6, not SLC25A6P2, which is a non-functional gene fragment.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 6 pseudogene 2 (SLC25A6P2).